Sun Pharma gets regulatory nod to sell generic Wegovy in India
The drugmaker will launch generic semaglutide, the active ingredient in Novo Nordisk's drugs Wegovy and Ozempic, in India under the brand name Noveltreat, once the semaglutide patent expires in March 2026
The drugmaker will launch generic semaglutide, the active ingredient in Novo Nordisk's drugs Wegovy and
Ozempic, in India under the brand name Noveltreat, once the semaglutide patent expires in March 2026
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
